Allergen immunotherapy, more commonly known as allergy vaccine, is the causal treatment of choice for allergic diseases, thanks to its ability to act against the allergic march (i.e., disease progression) by taking disease-specific allergen extracts.

The therapy duration varies from 3 to 5 years.

Allergoids in sublingual immunotherapy

«A Lofarma patent, the world’s only sublingually administered allergoid therapy.»

Immunoterapia specifica sublinguale con allergoide
Medico Lofarma

Monomeric allergoids

Monomeric allergoids are obtained through a specific and targeted chemical modification of the ε -amino groups of certain amino acids of the native allergen, without altering its molecular size and structure.

Monomeric allergoid immunotherapy is available in sublingual form (tablets and drops) and subcutaneous form.